I will find the exact citation, but when you are adding QCs within the previously validated range, you are not required to do a partial validation, only qualify the accuracy and precision of the new QC level prior to implementing. Since the QC performance is extrapolated to the full quantitative range in the original validation, I would also not redo stability. The exception, of course, is if the reason you are moving the QC is that it poorly represented the full quantitative range. An example could be if the old QC was on top of a calibrator so had artificially low variance. In that case, you would not be able to rely on the prior data for extrapolation.
------------------------------
Joleen White Ph.D.
AAPS 2026 National Biotechnology Conference Track Chair
Bioanalytical 101 Course Development
Senior Advisor
BioData Solutions LLC
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 08-05-2025 08:57
From: Hao Wang
Subject: Partial/Full Validation requirement of higher sensitive PK assay
Agree it's pretty much a full validation as many parameters are tested in LLOQ and LQC levels.
@Joleen White I also have a question for matrix stability (short term, F/T and LTS). The stability is established at LQC and HQC. If either LQC or HQC concentration is changed but still within the validated calibration range, should the stability be repeated at the new concentration, or the original stability can be accepted? Also, if later during sample analysis, another level of QC (eg. a LMQC between L and M) is added, will additional stability data of the LMQC be required, or not necessary as it is covered by LQC and HQC? Thanks!
------------------------------
Jason (Hao) Wang, Ph.D.
Resolian Bioanaytics,
Brisbane, Australia
Original Message:
Sent: 07-28-2025 09:58
From: Joleen White
Subject: Partial/Full Validation requirement of higher sensitive PK assay
You can theoretically do a partial validation, but given how many assessments are performed at the now lower LLOQ and LQC, it's basically a full validation.
------------------------------
Joleen White Ph.D.
AAPS 2024 Global Health Community Chair
Bioanalytical 101 Course Development
Senior Advisor
BioData Solutions LLC
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
Original Message:
Sent: 07-25-2025 10:02
From: Anonymous Member
Subject: Partial/Full Validation requirement of higher sensitive PK assay
This message was posted by a user wishing to remain anonymous
We have a validated clinical PK assay with an LLOQ of 10 ng/mL but require higher sensitivity (LLOQ ~2 ng/mL) to support lower doses. Using the original method, we can now achieve this sensitivity, with changes in LLOQ, LQC, and MQC. Do we need a full validation for the more sensitive PK assay?